Staff training and academic detailing for Tobacco Use

Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York, NY
Staff training and academic detailingN/AWaitlist AvailableLed by Scott E. Sherman, MD MPHResearch Sponsored by VA Office of Research and Development

Study Summary

This trial will study whether an opt-out or opt-in approach is more effective in referring smokers to treatment.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2-year intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-year intervention period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Abstinence at the end of the 2-year intervention period
Proportion of smokers who accept referral to treatment (Quitline or text messaging)
Proportion of smokers who engage in treatment with the Quitline or text messaging service
Secondary outcome measures
Cost-effectiveness of the two approaches (opt-out vs opt-in)
Use of smoking cessation medications

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Opt-out tobacco treatmentExperimental Treatment1 Intervention
The investigators will directly change the treatment status quo by implementing a clinical reminder that automatically initiates tobacco treatment referral at the time the reminder is activated.
Group II: Opt-in clinical reminderExperimental Treatment1 Intervention
As the investigators have done previously, the reminder will be self-explanatory, and will walk staff through each step of referral. The reminder will include the following domains: normative advice, referral to treatment, handout

Find a site

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,553 Previous Clinical Trials
2,888,830 Total Patients Enrolled
4 Trials studying Tobacco Use
3,669 Patients Enrolled for Tobacco Use
Scott E. Sherman, MD MPHPrincipal Investigator
Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY
1 Previous Clinical Trials
220 Total Patients Enrolled
Steven S. Fu, MD MSCEPrincipal Investigator
Minneapolis VA Health Care System, Minneapolis, MN
3 Previous Clinical Trials
10,714 Total Patients Enrolled

Media Library

Staff training and academic detailing Clinical Trial Eligibility Overview. Trial Name: NCT03477435 — N/A
Tobacco Use Research Study Groups: Opt-in clinical reminder, Opt-out tobacco treatment
Tobacco Use Clinical Trial 2023: Staff training and academic detailing Highlights & Side Effects. Trial Name: NCT03477435 — N/A
Staff training and academic detailing 2023 Treatment Timeline for Medical Study. Trial Name: NCT03477435 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers still accepting participants for this experiment?

"From the data hosted on, it is apparent that this study has ceased to recruit patients; with a first post date of August 28th 2019 and its last update being August 3rd 2022. Nevertheless, there are still 55 other studies actively enrolling participants as we speak."

Answered by AI
Recent research and studies
~27 spots leftby Nov 2023